As Consultant continues to evolve to meet the needs of today’s time-constrained clinicians, we remain committed to publishing concise, clinically actionable content, and we invite you to contribute.
GLP-1 medications are reshaping patient expectations. In this podcast, learn how dietitians guide safe, evidence-based care amid rising demand and misinformation.
Evan M. Masutani, MD, PhD; Mariam Fahim, DO; Peter Wei, DO
In this Consultant Case Report Insights, Evan M. Masutani, MD, PhD; Mariam Fahim, DO; and Peter Wei, DO, discuss their study, “A Rapidly Enlarging Headache,” which features a 6-year-old boy with recurrent...
In the next installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD, emphasizes a patient- and caregiver-centered approach to treatment planning—highlighting how clinical decisions...
In this Nutrition 411 podcast, experts unpack the updated pyramid, highlighting minimal changes and how dietitians can address confusion and misinformation.
Monitoring treatment response in myelofibrosis requires a balanced assessment of patient-reported symptoms, objective scoring tools, hematologic parameters, and spleen size. In part 1 of this Myelofibrosis...
In this video interview, Sean Rose, MD, a pediatric neurologist at Nationwide Children’s Hospital and The Ohio State University, discusses new research examining how frequently children younger than 6 years...
Lisa Jones, MA, RDN, LDN, FAND; Bonnie Chambers, MSN, FNP-C
This episode of Nutrition411 explores how clinicians and dietitians can set realistic, emotionally informed expectations for patients using GLP-1 medications for obesity.
In this video, Johannes Thrul, PhD, MS, associate professor at Johns Hopkins Bloomberg School of Public Health, discusses the new dietary guidelines that recommend reducing alcohol consumption for overall...
